Dunvegan Associates’s Cerus CERS Stock Holding History

Dunvegan Associates’s Portfolio CERS Stock Details CERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-500	Closed	-$2K	–	195
2014 Q1	$2K	Buy	+500	New	+$3.21K	﹤0.01%	207

Other funds holding CERS

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Dunvegan Associates's CERS Position: Q2 2014 in Review

Dunvegan Associates sold out of Cerus (CERS) in Q2 2014, closing a stake of 500 shares — an estimated $2K sold.

Dunvegan Associates first reported a position in CERS in Q1 2014 and held it in 1 quarter. The position peaked at $2K in Q1 2014. 83 funds tracked by Wall St. Rank hold CERS as of Q2 2014.

Dunvegan Associates reported no remaining Cerus position as of Q2 2014 after selling out during the quarter.
Dunvegan Associates sold 500 Cerus shares in Q2 2014, an estimated $2K.
Dunvegan Associates first reported a position in Cerus in Q1 2014 and held it in 1 quarter.
Dunvegan Associates's Cerus position peaked at $2K in Q1 2014.
83 funds tracked by Wall St. Rank held Cerus as of Q2 2014.

Based on Dunvegan Associates's 13F filing for Q2 2014, filed 28 Apr 2017.